Pharma Journalist - Page 904 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

Novartis to In-Licence ECF843 to Strengthen R&D pipeline

GE and CBMG collaborated to co-develop CAR-T and Stem Cell Manufacturing

GlucoMe Appoints John Erickson as EVP, General Manager North America

Abbott and Alere Amend Terms of Merger Agreement

FDA Allows NuvOx Pharma to Run a Phase II Clinical Trial in Brain Cancer

Aimmune Therapeutics Appoints Eric Bjerkholt as Chief Financial Officer

Second Sight’s Argus II Retinal Prosthesis Implanted in First Patient in Asia

Lyndra Raises $23 Million in Series A Financing to Advance Ultra-Long Acting Oral Therapeutic Delivery

Icon Bioscience Submits NDA for DEXYCU

BMS enters two separate agreement with Biogen and Roche